Ms Deborah Ann Hinton, LCPC | |
3930 Knowles Ave, Suite 200, Kensington, MD 20895-2428 | |
(240) 426-3217 | |
Not Available |
Full Name | Ms Deborah Ann Hinton |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 3930 Knowles Ave, Kensington, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063627917 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | LC0853 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Deborah Ann Hinton, LCPC 4406 Saul Rd, Kensington, MD 20895-3731 Ph: (301) 933-6268 | Ms Deborah Ann Hinton, LCPC 3930 Knowles Ave, Suite 200, Kensington, MD 20895-2428 Ph: (240) 426-3217 |
News Archive
Heparin plays a key role in allergic and inflammatory reactions driven by mast cells, scientists from Karolinska Institutet in Sweden shows in an international collaboration involving colleagues from Germany and Switzerland. The study is published in the recent issue of Immunity, and sheds some new light on the biological function of heparin.
Veeva Systems, the global leader in cloud CRM solutions for the life sciences industry announces the ability to integrate with Mederi, a leading provider of network intelligence and insights for the healthcare industry. The seamless integration between Veeva CRM and Mederi allows pharmaceutical companies to manage their customer relationships and to analyse professional networks within one application, ensuring a much more coordinated and effective interaction with key stakeholders.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
Clear Catheter Systems, Inc., a Bend, Oregon-based medical device company, announced today that it has received US Food and Drug Administration clearance for its innovative PleuraFlow™ Active Tube Clearance System. This is a device that can be widely deployed in the post operative management of patients requiring heart and lung surgery.
Study published in Nature outlines use of Wyatt's Calypso II system to confirm the stoichiometry of αSNAP-SNARE complex
› Verified 8 days ago
Cecelia A. Rubertone, Counselor Medicare: Not Enrolled in Medicare Practice Location: 9813 Gartrell Pl, Kensington, MD 20895 Phone: 301-742-5574 | |
Paige Prestipino, Counselor Medicare: Not Enrolled in Medicare Practice Location: 9901 Cable Dr, Kensington, MD 20895 Phone: 301-910-8117 | |
Ms. Ashley Thorndike, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 10410 Kensington Pkwy Ste 107, Kensington, MD 20895 Phone: 202-460-8887 | |
Emily Williams, LGPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3720 Farragut Ave Ste 301, Kensington, MD 20895 Phone: 240-242-5031 | |
Mrs. Paula Catalan, LCPC, CP Counselor Medicare: Not Enrolled in Medicare Practice Location: 10410 Kensington Pkwy, Suite 110, Kensington, MD 20895 Phone: 301-520-4880 | |
Lauren Kim, LCPC, LCPAT Counselor Medicare: Not Enrolled in Medicare Practice Location: 10605 Concord St Ste 206, Kensington, MD 20895 Phone: 301-861-2248 |